A detailed history of D. E. Shaw & Co., Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 567,731 shares of IDYA stock, worth $13.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
567,731
Holding current value
$13.4 Million
% of portfolio
0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.37 - $43.05 $9.62 Million - $13.6 Million
-316,807 Reduced 35.82%
567,731 $18 Million
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $7.79 Million - $9.84 Million
226,514 Added 34.42%
884,538 $31.1 Million
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $4.4 Million - $6.06 Million
128,518 Added 24.27%
658,024 $28.9 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $2.29 Million - $3.34 Million
93,148 Added 21.35%
529,506 $18.8 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $4.7 Million - $6.64 Million
223,143 Added 104.66%
436,358 $11.8 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $1.55 Million - $2.97 Million
116,156 Added 119.68%
213,215 $5.01 Million
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $1.03 Million - $1.42 Million
76,118 Added 363.49%
97,059 $1.33 Million
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $303,016 - $380,497
20,941 New
20,941 $380,000
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $203,605 - $341,309
-24,590 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$11.18 - $24.02 $256,323 - $550,706
-22,927 Reduced 48.25%
24,590 $275,000
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $580,524 - $744,844
27,710 Added 139.9%
47,517 $1.12 Million
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $341,868 - $536,373
19,807 New
19,807 $505,000
Q2 2021

Aug 16, 2021

SELL
$17.76 - $24.83 $342,643 - $479,045
-19,293 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$13.48 - $23.77 $133,505 - $235,418
-9,904 Reduced 33.92%
19,293 $453,000
Q4 2020

Feb 16, 2021

BUY
$12.17 - $17.52 $355,327 - $511,531
29,197 New
29,197 $409,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.14B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.